Noteworthy News Articles on Mental Health Topics, October 1-9, 2007 Associated Press, 10/1/2007 A legislative report shows more than 20 percent of Connecticut's approximately 19,000 prison inmates have moderate to severe mental illness. That fact is prompting some state lawmakers to point out an apparent shortage of trained psychiatric nurses and a need for more training for correction officers. Also, there's talk of creating a separate facility for inmates with mental illness to ease the space crunch. "Because there seems to be no other options, they end up being dumped in jail," Rep. Michael Lawlor, D-East Haven, co-chairman of the legislature's judiciary committee told the New Haven Register. "If you want to free up prison beds [to keep violent offenders behind bars longer], then get these mentally ill people out of there," Lawlor said. The study, conducted by the Office of Legislative Research, comes as the state's prison population continues to grow in the wake of the much-publicized killings of a Cheshire mother and her two daughters. Two parolees convicted of burglary have been charged with the crimes. Gov. M. Jodi Rell, a Republican, recently stopped parole for violent offenders temporarily. The legislature's judiciary committee has scheduled an emergency meeting today at noon to discuss the state's plans for handling the prison crowding situation considering Rell's new policy. Department of Correction Commissioner Theresa Lantz is scheduled to address the lawmakers. Lantz recently warned legislators she is already "running out of space" and cited the growing number of mentally ill inmates as one reason. She said the state could consider building a $150 million, 1,200-bed prison medical facility. But Rell, who has declined to address the committee today, sent a letter to lawmakers last week saying there are no plans to build any new facilities for the prison system. Since the Cheshire killings on July 23, the state prison population has grown by 280 inmates. Lawlor said that's because judges are setting higher bail amounts for burglars, plea deals have substantially increased and the state's Board of Pardons and Paroles has gotten more conservative in doling out parole approvals. Lawlor, in a recent interview with The Associated Press, said Connecticut's prisons were designed to handle 17,000 inmates but now hold about 19,000. Lawmakers, correction union officials and advocates for the mentally ill argue that Connecticut could cut its prison population if there were someplace else to care for the mentally ill offenders. "We've become society's mental health provider," Steve Curran, a correction officer at Garner Correctional Institution in Newtown, told the Register. The state's most seriously mentally ill inmates are housed at Garner. Curran said he believes prosecutors and judges are sending mentally ill people to prison for minor offenses because there is no place else for them to receive care. Connecticut closed its state-run psychiatric institutions in the 1980s and 1990s. Marital Spats, Taken to Heart Tara Parker-Pope, New York Times- 10/2/2007 Arguing is an inevitable part of married life. But now researchers are putting the marital spat under the microscope to see if the way you fight with your spouse can affect your health. Recent studies show that how often couples fight or what they fight about usually doesn’t matter. Instead, it’s the nuanced interactions between men and women, and how they react to and resolve conflict, that appear to make a meaningful difference in the health of the marriage and the health of the couple. A study of nearly 4,000 men and women from Framingham, Mass., asked whether they typically vented their feelings or kept quiet in arguments with their spouse. Notably, 32 percent of the men and 23 percent of the women said they typically bottled up their feelings during a marital spat. In men, keeping quiet during a fight didn’t have any measurable effect on health. But women who didn’t speak their minds in those fights were four times as likely to die during the 10-year study period as women who always told their husbands how they felt, according to the July report in Psychosomatic Medicine. Whether the woman reported being in a happy marriage or an unhappy marriage didn’t change her risk. The tendency to bottle up feelings during a fight is known as self-silencing. For men, it may simply be a calculated but harmless decision to keep the peace. But when women stay quiet, it takes a surprising physical toll. “When you’re suppressing communication and feelings during conflict with your husband, it’s doing something very negative to your physiology, and in the long term it will affect your health,” said Elaine Eaker, an epidemiologist in Gaithersburg, Md., who was the study’s lead author. “This doesn’t mean women should start throwing plates at their husbands, but there needs to be a safe environment where both spouses can equally communicate.” Other studies led by Dana Crowley Jack, a professor of interdisciplinary studies at Western Washington University in Bellingham, Wash., have linked the self-silencing trait to numerous psychological and physical health risks, including depression, eating disorders and heart disease. Keeping quiet during a fight with a spouse is something “we all have to do sometimes,” Dr. Jack said. “But we worry about the people who do it in a more extreme fashion.” The emotional tone that men and women take during arguments with a spouse can also take a toll on their health. Utah researchers have videotaped 150 couples to measure the effect that marital arguing style has on heart risk. The men and women were mostly in their 60s, had been married on average for more than 30 years and had no signs of heart disease. The couples were given stressful topics to discuss, like money or household chores, and the comments made during the ensuing arguments were categorized as warm, hostile, controlling or submissive. The men and women also underwent heart scans to measure coronary artery calcium, an indicator of heart disease risk. The researchers found that the style of argument detected in the video sessions was a powerful predictor for a man or woman’s risk for underlying heart disease. In fact, the way the couple interacted was as important a heart risk factor as whether they smoked or had high cholesterol, says Timothy W. Smith, a psychology professor at the University of Utah, who presented the study last year to the American Psychosomatic Society. For women, whether a husband’s arguing style was warm or hostile had the biggest effect on her heart health. Dr. Smith notes that in a fight about money, for instance, one man said, “Did you pass elementary school math?” But another said, “Bless you, you are not so good with the checkbook, but you’re good at other things.” In both exchanges, the husband was criticizing his wife’s money management skills, but the second comment was infused with a level of warmth. In the study, a warm style of arguing by either spouse lowered the wife’s risk of heart disease. But arguing style affected men and women differently. The level of warmth or hostility had no effect on a man’s heart health. For a man, heart risk increased if disagreements with his wife involved a battle for control. And it didn’t matter whether he or his wife was the one making the controlling comments. An example of a controlling argument style showed up in one video of a man arguing with his wife about money. “You really should just listen to me on this,” he told her. What’s particularly notable about the study is that the men and women filled out standard questionnaires about the quality of their relationships, but those answers were not a good predictor of cardiovascular risk. The difference in risk showed up only when the quality of the couple’s bickering style was assessed. “Disagreements in a marriage are inevitable, but it’s how you conduct yourself,” Dr. Smith said. “Can you do it in a way that gets your concerns addressed, but without doing damage at the same time? That’s not an easy mark to hit for some couples.” Talk Therapy Pivotal for Depressed Youth Benedict Carey, New York Times- 10/2/2007 A talking cure for depression called cognitive behavior therapy appears to cancel the risk of suicidal thinking or behavior associated with taking antidepressant medication, according to the most comprehensive and long-running study to date of depression treatment among adolescents. The study, which followed for a year more than 600 adolescents being treated for chronic depression, found that four in five recovered entirely, or nearly so, when treated over nine months with medication, talk therapy or a combination of the two. Patients taking medication showed significant signs of improvement up to six weeks earlier than those who received talk therapy alone, but were about twice as likely to report feeling suddenly suicidal. The combination of the two therapies, the authors found, produced the most rapid recovery and protected against sudden suicidal urges. For several years experts have been debating the risks to children and adolescents who take antidepressants like Prozac and Paxil. In 2004, health regulators required that all labels for antidepressants carry prominent warnings that the drugs were associated with increased risks of suicidal thinking and behavior in young patients, a link that many psychiatrists say has been blown out of proportion, scaring off patients who could benefit from drug treatment. In this study, antidepressants lowered the risk of suicidal thoughts and actions over all, but significantly less so than talk therapy. “What this study shows, convincingly and for the first time, is that there are very good options for a child who is thought to be at risk for suicidal thinking,” said Kevin Stark, a psychologist at the University of Texas, who was not involved with the research. “Psychosocial therapies do work on their own, with time. But they also help prevent relapse, and this shows that they can help make drug treatment safer.” In the study, which began in 1999, researchers recruited 654 youths ages 12 to 17 who had been moderately to severely depressed for up to a year or longer. The adolescents were randomly assigned to be treated with Prozac, the antidepressant made by Eli Lilly; cognitive behavioral therapy for a weekly hourlong session; placebo pills; or a combination of Prozac and talk therapy. After 12 weeks, about three in four of the patients receiving both talk therapy and medication were rated as “much better” or “very much better,” and two-thirds taking just the drug fared just as well. Talk therapy by itself was no better than the placebo. After four months, about two-thirds of those receiving any treatment were rated as much or very much improved — significantly better than a typical response to placebo pills. By nine months, 8 in 10 adolescents had shaken off their depression, entirely or almost entirely, no matter the treatment. Talk therapy was a safer alternative. Almost 15 percent of the patients taking just Prozac reported what were described as “suicidal events,” mainly talk and thoughts of suicide so alarming that doctors called in the patients and, often, altered dosages. The rate of such events for those receiving just cognitive behavior therapy was 6 percent. The results for combination therapy were about the same. “The message is that medication accelerates recovery, but cognitive therapy protects against these bad reactions, and the combination is the best option,” said Dr. John March, chief of child and adolescent psychiatry at the Duke University Medical Center and the principal investigator for the study. The talk therapy promoted changes in behavior like getting patients out of bed and doing something that they enjoy, like playing basketball or going to a party. It also provided cognitive therapy, in which patients are taught to diffuse poisonous assumptions like “I’m a loser” or “I’ll never get a girlfriend.” Experts say it is not easy to find specialists in this therapy outside large cities. The techniques have been widely published in manuals and books, and Dr. March said a good therapist could usually work such techniques into a treatment plan. “The trick,” he said, “is to be an intelligent consumer and find a skilled therapist who’s willing to work with you on these methods.” Benedict Carey, New York Times- 10/2/2007 To some, it may seem like an ideal relationship, less stressful than an affair, longer lived than a fling or that elusive one-night stand. You can even sit around in your sweats and watch “Friends” reruns together, feeling vaguely reassured. Yet relationships in which close friends begin having sex come with their own brand of awkwardness, according to the first study to explore the dynamics of such pairs, often called friends with benefits, or F.W.B.. The relationships tend to have little romantic passion, but stir the same fears that stalk lovers: namely, that one person will fall harder than the other. Paradoxically, and perhaps predictably, the study suggests, these physical friendships often occlude one of the emotional arteries of real friendship, openness. Friends who could once talk about anything now have an unstated taboo topic — the relationship itself. In every conversation, there is innuendo; in every room, an elephant. The research, conducted among Michigan State University students, confirmed previous findings that most college students report having had at least one such relationship. Although that is undoubtedly true of many couples throughout history, “friends with benefits” have become a cultural signature of today’s college and postcollege experience. “The study really adds to the little we know about these relationships,” said Paul Mongeau, a professor of communications at Arizona State University who was not involved in the research. “One of the most interesting things I get from it,” he said, “is this sense that people in these relationships are afraid to develop feelings for the other person, because those feelings might be unreciprocated.” In the study, appearing in the current issue of Archives of Sexual Behavior, Melissa Bisson, a former graduate student at Michigan State, and Timothy Levine, a professor in the communications department, surveyed 125 young men and women and found that 60 percent reported having had at least one friend with benefits. One-tenth of these relationships went on to become full-scale romances, the study found. About a third stopped the sex and remained friends, and one in four eventually broke it off — the sex and the friendship. The rest continued as friends-with-benefits relationships. In a follow-up study, the researchers gave 90 students who reported having at least one such relationship a battery of questionnaires asking about passion, commitment and communication. “We found,” Dr. Levine said, “that people got into these relationships because they didn’t want commitment. It was perceived as a safe relationship, at least at first. But also that there was this growing fear that the one person would become more attracted than the other.” Yet, he added, the overall qualities of the relationships appeared to be true to the name. On standard psychological measures, they appeared more like friendships than romances. Friends with benefits scored in the middle on a scale assessing intimacy and low on passion and commitment, the study found. “When scores were compared to previous findings with romantic couples, scores on all three dimensions were lower, with the largest differences observed in commitment followed by passion,” the authors wrote. The relationships may be less common than reported. “Friends with benefits” appears to have become an umbrella term for a wide variety of sexual arrangements, some of which are quite familiar, Dr. Mongeau said. In addition to budding romances, he said, the “friends” may also be former lovers who occasionally see each other or they may be people who hang out at the same places and now and then end up wrapped around each other, even though they are not really friends. Dr. Mongeau said the study seemed to have captured the dissonant, circular thinking that characterized what it felt like for a friendship to enter treacherous territory. “There’s clearly a strong desire to be with this other person, who fills important needs,” he added. “But at the same time, it’s as if I’m saying, ‘O.K., I’m not going to get passionately involved — because then it’s at risk of being a real romance.’”
But the man, now 40, was charged as a juvenile because of his age at the time of the alleged offenses, in a type of case that is becoming more common as women increasingly report being molested as children. "I deal with this every day of my life," Gandhi, 33, told the man in court, according to a copy of her prepared remarks. "I hope that's something you think about every day of yours." Cases such as the one prompted by Gandhi's report to police last year have ignited a legal debate about whether adults can and should be tried in juvenile court and whether labeling adults as sex offenders for things they did as teenagers is fair and necessary. Gandhi says the criminal justice system let her down. Montgomery County prosecutors dropped the charges against her former neighbor after clinical experts concluded that he is unlikely to offend again. The man had admitted the abuse in a telephone conversation recorded by police last summer, according to a police report. Although Gandhi was given an opportunity to confront him in court the day the case was dropped, she says the main goals of her decision to come forward -- accountability and public safety -- remain unfulfilled. The case file is not open to the public because it was handled in juvenile court. Her former neighbor was not found to have committed the offense, and he was not subjected to the scrutiny of adult court. "It shouldn't be a secret he gets to keep," Gandhi said. "If you have a child, do you want this man as your child's teacher, soccer coach, taking him on a camping trip?" The Washington Post is not naming the man because it generally doesn't publish the names of juveniles charged with crimes. It also usually does not print the names of victims of sexual crimes, but Gandhi asked that her name be printed because she said she wants to draw attention to the issue. Her former neighbor declined to be interviewed. His attorney, Alan L. Fishbein, said that prosecuting his client as an adult would have been unfair. "My client had an exemplary life and never had any difficulties" with the law, he said. Montgomery Assistant State's Attorney Kathy Knight said she is barred from discussing the case because it was handled in juvenile court. Speaking generally, she said, old sex cases involving people who were juveniles at the time present a tough balancing act. Beyond the ages of the offender and the victim at the time of the crime, the nature of the offense and the evidence at hand, prosecutors look for signs that the offender remains a threat to children, and they weigh the potential ramifications of a conviction. Prosecutors also rely heavily on expert assessments of the threat level of offenders and the extent to which they have sought roles of responsibility around minors, Knight said. "We have to look at each one and try to be fair," she said. "To have all the sanctions and consequences of adult court for something they did when they were 13 or 14 -- that's huge." The disposition of Gandhi's case appears to be an exception among the dozen or so such cases that have been investigated in the area in recent years, according to lawyers involved in them. Most cases started in juvenile court but were transferred automatically because prosecutors argued that the juvenile system doesn't have jurisdiction over people 21 and older. Some lawyers have recently argued that Maryland's highest court has ruled that judges have the discretion to keep some cases in juvenile court. However, the Department of Juvenile Services has refused to conduct assessments or make recommendations on which court the cases belong in. In the District and Virginia, prosecutors generally charge adult offenders in regular court regardless of how old they were when the offense was committed, according to lawyers who have researched the issue. Rockville lawyer Stephen Mercer has a client who is appealing the transfer of his case, without a substantive hearing, to adult court. Mercer said that adults who molested younger children as teenagers should be prosecuted in juvenile court -- if at all. His client, a 26-year-old Olney man, was fired as a Prince George's County police officer after being accused in December 2005 of molesting a child he babysat for in 1996 and 1997, according to court records. The case began as a juvenile proceeding but was transferred to Circuit Court. The case has not gone to trial; prosecutors agreed to await the results of the appeal. The following account of Gandhi's case is supported by an interview with Gandhi, a copy of the police report and e-mails between Gandhi and Knight, the prosecutor, which Gandhi provided to The Post. The incidents occurred when Gandhi was about 7 and living in Montgomery. A neighbor, then about 14, was a friend of one of Gandhi's older brothers, and she went to his house frequently. On some of those occasions, he fondled her, she said. She told no one. For years, Gandhi said, she suppressed memories of the abuse. But they resurfaced. "I remember feeling very frightened, trapped, sort of paralyzed," she said. In March last year, she contacted police. "It was empowering: Finally I'm the one making decisions over some of this," she said. Detectives took Gandhi's statement and told her that they would arrange a phone sting. During a conversation that detectives recorded in June 2006, the man apologized profusely. "I knew it was wrong, but it was something I knew I could do," he said, according to the police report. "I couldn't stop myself."In the conversation, he also told Gandhi that he had been molested by a female cousin when he was a child and that he had molested another child, according to Knight's e-mails. "I so regret how I hurt you," he said, according to the police report. "I wish I could take your pain away." The remarks led detectives to charge the man with three counts of third-degree sex offense. The man agreed to undergo a clinical risk assessment evaluation. Gandhi was not shown the evaluation, but prosecutors told her that it did not suggest that her former neighbor was likely to abuse children or that he had done so as an adult. Research on juvenile sex offenders shows they are more likely than adults to respond to treatment. And experts say many juveniles who commit sex offenses don't do so as adults. Ronald I. Weiner, director of Clinical and Forensic Associates, a Washington-based agency that evaluates sex offenders in criminal proceedings, said his office has been asked in recent years to assess the risk level of about a half-dozen adults charged in sex offenses they allegedly committed as juveniles. "There was no evidence of subsequent abuse into adulthood," he said, noting that the low number makes it impossible to draw solid conclusions. Still, Gandhi thinks authorities failed to cast a wide net in part because investigators must protect the privacy of juveniles in delinquency proceedings. "It's a tough balance between privacy concerns and what's best for the general public," said Frank Darley, a Montgomery family crimes detective. Before the case was dropped, Gandhi told prosecutors she was upset by their decision. She said they told her they took into account that the former neighbor had been forthcoming and apologetic. "I know it took a lot of courage to finally come forward," Knight wrote to her in an e-mail. "But circumstances are very unusual in this case. We are not talking about punishing someone for something they did as an adult. We are looking at the behavior of a 14 year old boy. He was just a kid too. And while what he did was horrific, we cannot lose sight of the fact that he was a kid when he did it." The state Medicaid program is analyzing records of 82,900 children under age 5, looking for those taking at least three psychiatric drugs or a single prescription of a powerful antipsychotic drug. Mental health professionals will review the care of these children and, if necessary, contact the prescribing doctor for an explanation, say officials of the state insurance program for lower-income families, known as MassHealth. Although cases like the overdose of Rebecca Riley are rare, the prescription of psychiatric drugs to young children is not. Doctors last year prescribed Clonidine - a drug sometimes used to treat hyperactivity that was found in lethal quantities in the Hull girl's bloodstream - to 955 children under age 7 in MassHealth. Doctors also prescribed antipsychotic drugs, which raise the risk of diabetes and obesity, to 536 children under age 7, according to MassHealth records. MassHealth could not say how many of these cases involve children under age 5 and might be subject to review. Some psychiatrists have been concerned for years about the rise of psychiatric drug treatment of young children, largely because few preschoolers are old enough to show clear signs of mental illness and there are almost no studies on how the chemicals affect their developing brains. But until Riley's death from three drugs she was taking to treat bipolar disorder and hyperactivity, the state provided little oversight of doctors' prescribing practices. Riley's death "was a wake up call," said Dr. John Straus, vice president for medical affairs at the Massachusetts Behavioral Health Partnership, one of the organizations that manage mental health care for children in MassHealth. He said MassHealth managers want to make sure that doctors have good reason for prescribing psychiatric drugs to such young patients and that they are not relying solely on the parents or guardians for information about each child's condition. Riley's parents have been charged with deliberately giving her a fatal overdose. "If the behavior is extreme enough to require this level of medication, we ought to make sure that the behavior exists," said Straus, by checking with day-care providers and other independent observers. The oversight system is too new to say how many cases will merit contacting the prescribing doctor, officials said, but the largest provider of mental health services for MassHealth - Massachusetts Behavioral Health - identified 35 preschoolers in the first three months of the system who were taking three psychiatric medications or one antipsychotic drug. Four other managed-care organizations have also begun reviewing children's MassHealth prescription records, but their findings have not been released. Nonetheless, Straus said he hopes that fewer than 100 children under age 5 enrolled in MassHealth will trigger the early-warning system in the course of a year. Deputy Mental Health Commissioner Robert J. Keane, who led the effort to create the tracking system, stressed that it isn't meant to punish doctors or second-guess their judgment. He noted that some children, such as those who are extremely self-destructive, may need multiple medications. However, he said MassHealth's outreach could help some doctors make more informed decisions when they prescribe drugs for very young children. "Clinical decision making often happens in isolation. It's a problem in healthcare," said Keane, suggesting that some doctors may not realize they are overprescribing psychiatric drugs to preschoolers. Until the 1990s, children under age 5 were rarely treated with psychiatric drugs for mental illness, in part because the conditions are hard to diagnose in children too young to discuss their feelings or control their impulses. But by 2000, Dr. Joseph T. Coyle of McLean Hospital in Belmont was warning of a "growing crisis in mental health services to children" amid reports that the number of preschoolers taking drugs for attention deficit/hyperactivity disorder had doubled in four years. Writing about a major study of preschool psychiatric drug prescriptions in the Journal of the American Medical Association, Coyle argued that disturbed children were getting drugs as a "quick fix" instead of more time-consuming therapy and other family services. Riley's death focused attention on the growing use of drugs among preschoolers for another condition, bipolar disorder, which is characterized by wide mood swings and was once thought to begin in late adolescence. Her doctor, Kayoko Kifuji, diagnosed the girl with the condition when she was 2 1/2 years old. Kifuji has voluntarily given up her license to practice medicine while regulators investigate her treatment of Riley, and the girl's mother, Carolyn Riley, said on "60 Minutes" last Sunday that she no longer believes her daughter was bipolar. The parents blame Kifuji for their daughter's death, though she denies wrongdoing. Despite unease over the amount of psychiatric drugs being prescribed to preschoolers, few states have tried to rein in prescriptions beyond drug educational programs for doctors or other forms of doctor assistance, such as Massachusetts' popular network of psychiatrists who are available for instant phone consultations concerning young patients. However, one state's experience is instructive: Texas officials adopted an early-warning system last year for mental health care of children in state foster care, and they saw an immediate drop in prescriptions of psychiatric drugs for children under 18 once they started contacting doctors who prescribe large amounts of psychiatric medication. Since 2004, the percentage of foster children receiving at least one psychiatric drug prescription has fallen from 29.9 to 24.4 today. "Just the fact that doctors are being asked to get involved in this discussion, they are going to be a little more reflective about what they are doing," explained Ted Hughes, spokesman for the Texas Health and Human Services Commission. He added that foster children tend to have a higher rate of medication than others because they often face complex emotional problems. MassHealth officials said it's unclear whether Massachusetts needs to reduce the rate of drug prescriptions to young children: their records show that the number of young children receiving antipsychotic drugs began declining in 2005. Keane said that most psychiatric drug prescriptions for preschoolers are written by child psychiatrists rather than pediatricians or family doctors, meaning that trained specialists are making the drug decisions. Riley's doctor was a child psychiatrist at a Boston teaching hospital, Tufts-New England Medical Center. Under the early-warning system, managed care organizations are reviewing prescription records for all children under age 5 who are receiving mental health treatment paid for by MassHealth. They are expected to keep a closer eye on those who are taking drugs and to conduct a case review of children receiving an unusual quantity or an antipsychotic. The reviewers will be looking to make sure that the high rate of prescriptions is not an error caused by more than one doctor writing them, and checking to make sure the drugs don't have dangerous side effects when taken together, Straus said. They will also look at the child's history for signs of abuse, evidence of emotional problems, and other issues aside from mental illness that could explain behavior problems. The point is to make sure doctors try other forms of treatment or social services before turning to drugs, Straus said. Straus said he is encouraged by results of the early-warning system. He said the behavioral health partnership has only contacted a handful of doctors so far to discuss prescriptions for at-risk children, but they had reasonable explanations for the children's treatment plans. "They were being thoughtful about it," he said. Keane said the new system is an experiment since apparently no other state has done something quite like it before. But, if the tracking system works, he said, it could be expanded to many of the 300,000 Massachusetts children under age 5 who are not in the MassHealth program. "This is really the start of this process," he said. The women were enrolled in the larger Women’s Health Initiative Observational Study, which is looking into the risk factors for heart disease, cancer, fractures and other causes of mortality among postmenopausal women. The current study, published in the October issue of The Archives of General Psychiatry, was partly financed by Glaxo Wellcome, now called GlaxoSmithKline. The researchers found that women who had panic attacks were also more likely to smoke, and to have high blood pressure, diabetes and symptoms of depression, as well as a history of cardiovascular problems. The increased risk for women who had had even one panic attack during the six-month period was still present. “This is consistent with previous studies that have suggested that certain negative emotional states can be associated with adverse medical outcomes,” said Dr. Jordan W. Smoller, the lead author and an associate professor of psychiatry at Harvard. But he added, “We can’t say whether the association with panic attacks is a direct causal connection or whether the panic attacks are a proxy for some other factor.” The drug, Topamax, works in a different way than three other medications already approved for treating alcoholism. Experts said the drug is likely to appeal to heavy drinkers who would rather seek help from their own doctors, rather than enter a rehab clinic to dry out. The drug costs at least $350 a month, plus the price of doctor's visits. But side effects are a problem, and it's unclear whether the findings will make a dent in an addiction that affects millions of Americans. Addiction specialists not involved in the study said the findings are promising, although side effects such as trouble concentrating, tingling and itching caused about one in five people to drop out of the study. Drowsiness and dizziness are also problems. ''The size of the treatment effect is larger than in most of the other medications we've seen,'' said Dr. Mark Willenbring of the National Institute on Alcohol Abuse and Alcoholism. ''And all the drinking variables changed in the right direction.'' The study, published in Wednesday's Journal of the American Medical Association, was funded by the maker of the drug, Johnson & Johnson Inc.'s Ortho-McNeil Neurologics. The researchers also reported financial ties to the company. Ortho-McNeil reviewed the manuscript, but did not change the results or interpretation, the researchers reported. The study followed 371 heavy drinkers for 14 weeks. About half were randomly assigned to take Topamax, also called topiramate, in gradually increasing doses. The others took dummy pills. All volunteers were encouraged -- but not required -- to stop drinking. At the start of the study, they drank, on average, 11 standard drinks daily. That's about two six-packs of beer each day, or two bottles of wine, or a pint of hard liquor. By the end of the study, 27 of the 183 people, or 15 percent, who took Topamax had quit drinking entirely for seven weeks or more. That compared to six out of 188, or 3 percent, in the placebo group. Others cut back. The Topamax group cut back to six drinks a day, on average, assuming everyone who dropped out of the study relapsed into heavy drinking. That compared to seven drinks a day for the placebo group. ''You can come in drinking a bottle of scotch a day and get treatment without detox,'' said Dr. Bankole Johnson of the University of Virginia, who led the study, which was conducted at 17 U.S. sites from 2004-2006. The study didn't follow the drinkers long-term, so it's unclear how many relapsed after they stopped taking the pill. But there were lasting effects for Tom Wolfe, 44, a carpenter from Earlysville, Va., who said he has been sober for two years thanks to Topamax. After years of heavy drinking, he took part in an earlier Topamax study. He felt ''a little lightheaded'' at first until he got used to the drug. Alcohol lost its enjoyment, strengthening his resolve to quit. ''It's been a miracle to me,'' Wolfe said. ''It got the monkey off my back.'' The drug works by inhibiting dopamine, the brain's ''feel-good'' neurotransmitters that are involved in all addictions, said Stephen Dewey, a neuroscientist the Brookhaven National Laboratory, who was not involved in the study but does similar research. It's a new approach, he said, that ''clearly did work on a very small subset in the population.'' Willenbring, who wrote an accompanying editorial, predicts that a future pill, although probably not Topamax, will do for alcohol dependence what Prozac did for depression: Remove the stigma. Prozac changed the nature of depression treatment 20 years ago by allowing patients to see their family doctors for help, Willenbring said. An effective drug with few side effects could do the same for alcoholism treatment, he said. ''This is a huge market,'' Willenbring said. ''We're approaching a Prozac moment.'' But Topamax has big obstacles. With the drug maker's patent expiring next year, there won't be any big push to advertise it for alcoholism, Willenbring said. Doctors are free to prescribe drugs for uses that have not been approved, but drug companies are prohibited by law from marketing drugs for these so-called ''off-label'' uses. On Tuesday, Dr. Sidney Wolfe, director of Public Citizen's health research group, sent a protest letter to the U.S. Food and Drug Administration questioning the promotion of Topamax for alcoholics by researchers funded by Ortho-McNeil. ''This is a very bad message to send out,'' Wolfe said. Ortho-McNeil has no plans to seek federal approval for the drug as an alcoholism treatment and promotes it only for its approved uses of migraine prevention and epilepsy, said company spokeswoman Tricia Geoghegan. The company dropped development of new uses for the drug in 2004, but has continued to support some research. On the Net: JAMA: http://jama.ama-assn.org The Trouble with Rehab, Malibu-Style Paul Pringle, Los Angeles Times- 10/9/2007 Hollywood rehab can produce unhappy endings, even when the patient isn't named Lindsay or Britney. That's what Kelly Logan learned when he sought treatment for a methamphetamine addiction at Promises Malibu, detox destination to the stars. Logan's brother, Garfield, says he paid $42,000 up front to admit the former professional surfer for a month at Promises' canyon-top Mediterranean-style home. Five days later, he says, Promises kicked Logan out for belligerent behavior but kept all the money. "They're scam artists," said Garfield Logan, a plaintiff in one of four consumer-rights, breach-of-contract and unfair-business-practice lawsuits filed against Promises Malibu and its Westside branch in the last year. Promises has denied the allegations. The suits and state licensing violations reveal a little-seen side to the high-end rehabilitation centers that have become a Malibu cottage industry and -- thanks to such patrons as Promises alums Lindsay Lohan and Britney Spears -- a tabloid feeding ground. The legal problems also reflect how the Malibu properties -- the area has one of the densest concentrations of rehab retreats in the nation, experts say -- can differ from industry norms, as represented by the Betty Ford Center, Hazelden, Phoenix House and other leaders in addiction treatment. All of the Malibu centers are for-profit enterprises in a field dominated by not-for-profits. With luxury as a principal appeal, many charge far more than the going rate for residential care. Court records indicate that Promises' fee is more than double the $23,000 cost for a month at Betty Ford. At the same time, Promises and fierce rival Passages Addiction Cure Center make sweeping claims on their websites about their clinical successes and reputations, purporting to have few or no equals in the world. Addiction researchers say the boasts are virtually impossible to substantiate. In addition, Promises, Passages and other Malibu rehab firms have identified on their websites a number of psychiatrists and other physicians as staff members, even though the centers are not licensed to provide medical care. Instead, they are limited to offering services such as detox monitoring that does not require medical treatment; group and individual counseling; and addiction education, state officials say. Over the last few years, Promises and several other centers that do business in Malibu have been cited by state regulators for providing medical services outside the scope of their licenses. Until recently, the Promises website said the center had a medical staff led by Jack Kuo, director of psychiatry; and Robert Saltzman, medical director. The site no longer refers to a medical staff, and it describes Kuo and Saltzman as "independent affiliates" with the title "independent detox specialist." The changes occurred after The Times inquired about Promises' operations. The center did not respond to questions about the physicians, and attempts to interview Kuo and Saltzman were unsuccessful. Two doctors, Robert Waldman and M. David Lewis, have been listed as staff internist and psychiatrist, respectively, and sometimes "addictionologist," on the websites of at least three of the 11 centers that run rehab houses in the Malibu area. Renaissance Malibu described Lewis as an "adjunct" staffer; Waldman was listed as the "medical director" of Cliffside Malibu, but his staff designation has been changed on the website to "M.D./detox." Bruce Moorman, intake coordinator at the Canyon, a center that identifies Waldman and Lewis as staffers, said there was nothing misleading about the characterization. "They take care of our clients," Moorman said. "They're on site more than not." Don Grant, director of Harmony Place, whose website also lists Waldman and Lewis under the staff heading, said they do not provide medical care but "monitor the detox" of patients. The state cited Harmony in 2005 for advertising "medical detoxification services" on its website and contracting with physicians. Grant said Harmony now strictly adheres to the state rules and that Waldman and Lewis are part of the center's "ancillary staff." "They are not paid by us," he said. "Our clients contract with them independently." Asked about the website staff listings for several Malibu centers, Lisa Fisher, spokeswoman for the state Department of Alcohol and Drug Programs, which licenses the firms, said the agency planned to investigate. "There should be no medical staff," Fisher said. "No medical services." Fisher said the Malibu centers are allowed to recommend doctors to patients but that they should not create the impression that they have in-house physicians available to prescribe and administer drugs or provide other types of medical care. Similarly, physicians are permitted to serve as counselors at rehab centers, but even in that role, they must refrain from practicing medicine as staff members, said Rebecca Lira, deputy director of licensing and certification for the alcohol and drug department. "I have never seen a physician who is only a counselor," Lira said. Since 2002, the state alcohol and drug agency has cited nine of the centers that operate in Malibu for a total of about 20 substantiated licensing violations, records show. These included improper administering of medications and TB tests; contracting with physicians; operating beyond patient capacity; failing to have staff members trained in first aid and cardiopulmonary resuscitation; and for an employee's having sex with a patient. State officials said the problems were corrected. By contrast, the four Phoenix House centers for adults in Los Angeles and Orange counties -- which together have about 230 beds, compared with 167 in Malibu -- have received no citations in that five-year period. Malibu Ranch Treatment Center closed in January after regulators said they found that alcohol and illicit drugs had been taken onto the premises; it had no licensed or registered counselors; staff members did not supervise residents; it exceeded its treatment capacity; and its sewer line was clogged. Malibu Ranch director Jerry Schoenkopf said the violations were technical. "We didn't close down because we were running a substandard treatment center," he said. "We were having economic problems." Schoenkopf said his center was an affordable alternative in Malibu, with a monthly fee of $15,000, and that it treated many low-income patients free of charge. In recent years, clean and sober retreats have mushroomed in the privileged environs of Malibu. The firms licensed in Malibu operate more than two dozen rehab houses there. Some are clustered in adjoining or nearby residences. "What is taking place in Malibu is rather unique," said Michael Cunningham, chief deputy director of the state alcohol and drug department. He said most communities have a dire shortage of rehab beds. "Clustering is not the norm." Some of the Malibu centers are known for lavish accommodations, including 500-thread-count sheets, gourmet meals and ocean views. Passages offers multiple mansions; marbled baths; 65-inch flat-screen televisions; and massage, acupuncture and hypnotherapy rooms. Many of the Malibu firms typically demand a month's payment in advance and refuse to refund any portion if the patient leaves treatment early or is expelled. No-refund policies at more traditional centers often apply to just part of the fee -- $5,000 in the case of Betty Ford, for example. Cynthia Moreno Tuohy, executive director of NAADAC, the Assn. for Addiction Professionals, said such no-money-back rules are an exception and "a shame." "People do leave programs, they do get expelled from programs when they act out," said Tuohy, whose organization has about 11,000 members. "That's not a reason not to be reimbursed for services that aren't received. It's important not to take advantage of someone who is ill." Promises and other centers say the stringent financial terms motivate patients to complete their treatment and are spelled out in admissions contracts. Promises lawyer Gerald Sauer said that when patients leave early, the balance of the month's payment is retained for their use if they check back in, or the money is sometimes transferred to other rehab centers where the patients seek treatment. "No one is losing any money," he said. But former patients and their relatives who have taken Promises to court maintain that the company intended to unjustly enrich itself at their expense by refusing to refund any money, no matter how short the patients' stay. "They get people at their most vulnerable point to turn over huge sums of money," said Michael Parks, a lawyer for a former patient identified only as John Doe, a 50-year-old lawyer and alcoholic who sued in July. "Promises has a double standard of caring for celebrities first, at the expense of regular people." The suit accuses Promises of evicting the plaintiff after a week -- and keeping the balance of his $49,000 payment -- because of false claims that he had made a "sexually inappropriate remark" to an unnamed celebrity patient. The Promises staff tolerated "racially insensitive comments" by a celebrity, the suit alleges. Promises denied the allegations. A hearing is set for November. Tucky Masterson said she wasn't in her right mind when she paid about $35,000 for a month at Promises. "I was on heroin," she said.Masterson left Promises after two stays that totaled about a week, according to a suit she filed in 2003. She said she eventually received $15,000 in a settlement, minus legal fees. "I was treated at Hazelden -- I was there for three days -- and they charged me to the penny for those three days," said Masterson, 48, who runs a sobriety house for women in Huntington Beach. "With Promises, I had to fight tooth and nail to get any money back." Her story mirrored those of other plaintiffs and their relatives. Sauer said Promises did nothing wrong. "Just because someone files a lawsuit, does that mean anything?" he asked. In 2004, the state cited Promises for providing medical services, administering TB tests and having doctors conduct physical exams at its Westside location, all of which it was not licensed to do, records show. Fisher, of the state agency, said Promises stopped the practice as a result. Promises founder and Chief Executive Richard Rogg declined through a publicist to be interviewed for this article. Among the other Malibu rehab centers with no-refund policies are Renaissance, whose website features a testimonial by actor Daniel Baldwin, and Passages, which counts fashion designer Marc Jacobs among its graduates. "If you leave, your money stays," said Passages co-founder Chris Prentiss, who added that the center immediately resells the vacated bed -- the monthly cost is $67,550 -- and that returning patients must wait for the next opening. Their payment stays on account, he said. In the last six years, Prentiss said, only seven patients have departed early and failed to complete treatment later. In 2005, the state cited Passages for exceeding its patient capacity. The center complied with a corrective order, Fisher said. Passages says on its website that it has the "highest cure rate in the country" and is "renowned as the most successful alcohol rehab and drug treatment center in the world for many reasons." Addiction researchers have criticized Passages for saying that it cures patients. "A cure? That's pretty good," Scott Walters, a University of Texas School of Public Health professor, said facetiously. Walters co-wrote a landmark 2001 study on treatment success rates. "People have been making claims about successful treatment since the dawn of time, since the snake-oil salesmen," he said. Prentiss says his center eliminates dependencies by treating their underlying causes -- depression and anxiety, for example -- through intensive one-on-one therapy. Passages also disdains Alcoholics Anonymous' 12-step program, which Promises and other Malibu centers have adopted or adapted. "We have an 84.4% success rate since we opened our doors in 2001, the highest in the world," Prentiss said. Not to be outdone, Promises declares on its website that it is designed for "anyone wanting the finest rehab program in the world." Promises attorney Sauer did not respond to questions about the basis of those statements. The center also declined to put The Times in contact with former patients who could provide testimonials. "Anybody can make any claim they want and get away with it," Walters said. "It's essentially an unregulated industry." At Therapy's End Josh Fischman, Los Angeles Times- 10/9/2007 People come into Andrew Leuchter's office, saying they're better, saying they want to stop. "Oh, gosh, it happens all the time," says Leuchter, a psychiatrist at UCLA's Semel Institute for Neuroscience and Human Behavior. "They say they feel OK, that they don't need drugs or any other help, and that they've recovered. On one hand that's very encouraging, but on the other hand we have to be very careful, because the cost of being wrong -- if they are not ready -- can be very high." These are not drug addicts saying they want to go cold turkey. They are not alcoholics. These are people with depression who want to stop treatment.Nearly 20 million Americans suffer from some form of depression, according to the National Institute of Mental Health. About 14% of adults now take antidepressants -- triple the percentage during the late 1980s -- and most stay on them for at least six months. A study published in this month's issue of the Archives of General Psychiatry estimated that mental disorders, largely depression, cost Americans 1.3 billion days of normal activity each year. Many people with such illnesses say they feel hopeless, helpless, unable to face life, unable to find solutions to their problems, and at times think of killing themselves. Some of them do. Depression treatment, such as antidepressant drugs Prozac or some version of talk therapy, can help about two-thirds of sufferers. But as it does, patients start to ask: Am I better? Am I cured? Can I stop my therapy? The answers are not simple. Measuring depression is hampered because there's no physical marker that indicates whether a patient has it or does not. Information about that comes from behavior, thoughts and feelings, which can't be assessed as easily as, say, blood pressure. Rating scales can show how far symptoms, such as trouble sleeping, have receded, but psychiatrists say they put even more stock in a patient's overall mood: whether he or she takes joy from life again and whether the person thinks he or she is back to a pre-depression emotional state. That too can be difficult to determine. Now results from large, long-term studies are beginning to paint a clearer picture of the course of depression and are sharpening decisions about stopping treatment. If a person has had just one episode of depression, the chances of a long-lasting recovery are fairly good. But those chances go down with every subsequent episode. Once people reach their third episode, Leuchter says, "then we need to discuss ongoing maintenance therapy, even if they are feeling better. I don't like to use the phrase 'lifetime treatment' with patients. But, essentially, that's what we're talking about." A lingering battle One woman, a 41-year-old professional pet sitter who lives in Los Angeles, has been battling depression since she was a child. (She prefers to remain anonymous because, she says, depression is still a taboo subject.) "I lost my dad when I was 10, and I never seemed to be able to get over it," she says. She remembers crying on the school bus, crying a lot. At home, she didn't want to get out of bed. Her body ached with a vague pain. She says at times she had to push herself to go to the bathroom. She had trouble seeing herself growing older. There didn't seem to be any point. But it wasn't until she was 22 that she got some help. "I was working as an aide in a pediatrician's office, and I was just crying all the time. It was over nothing, but it was uncontrollable," she says. "One day the doctor took me aside. He said, 'Look, we can't help you here with something like this. But you can get help.' And it was the first time somebody used the word 'depression' with me. It was the first time somebody took me seriously." The pediatrician referred her to a psychotherapist and to other doctors who prescribed antidepressants. She saw the therapist for a year and a half, "and I learned coping skills. I learned not to internalize things completely all the time." Medications were a rockier road. "I went through Paxil, and then Wellbutrin," she says. "I would be fine for a time. Then I would go back to being depressed." It's not unusual for patients to try multiple antidepressants and multiple dosages. There's a lot of tinkering, because doctors still don't understand precisely how these medications work. They have theories. The dominant one involves maintaining a balance in the brain of chemicals that seem to be involved in mood and emotions. When Prozac, the granddaddy of modern antidepressants, was approved by the Food and Drug Administration in 1987, it was because taking the drug improved the moods of depressed patients. Doctors then knew the drug made more of the chemical neurotransmitter serotonin available in the brain. They assumed -- and still think -- the two things are connected. Serotonin flows across tiny gaps from one brain cell to the next. Then the cell that originally released the chemical absorbs it again. The process is called reuptake. What Prozac appears to do is block that reuptake, so more serotonin lingers in the gap, ready to be taken up by other brain cells. If depression is indeed caused by low serotonin levels, this method -- while not increasing the absolute amounts of the chemical in the brain -- should leave more serotonin out in the open for more brain cells to use. Some antidepressants, such as Effexor, do the same thing with another mood-regulating brain chemical, norepinephrine. Still, because no one really knows what a low, normal or high level of these neurotransmitters is, there's a lot of trial and error involved in taking the drugs. "We use many different doses and many different drugs because people seem to respond to them differently," says Ellen Frank, a clinical psychologist at the Western Psychiatric Institute and Clinic at the University of Pittsburgh Medical Center. She has spent 25 years studying depression treatments. "Once we find something that works for a patient, we tend to stick with it," she says. "The dose that gets you well keeps you well." That view is supported by results of a major study that followed 3,600 patients across the country for several years. One-third of them responded to the initial antidepressant treatment. People who did not respond were given a different drug, and some also got talk therapy. After that, non-responders got another combination. By the time the fourth combination was reached, 67% of the patients were no longer depressed. That's good news and not-so-good news, says A. John Rush, a psychiatrist at the University of Texas Southwestern Medical Center who led the study, which is known as STAR*D. The good news is that there's hope for patients who can hang in there for multiple attempts at treatment. The not-great news, he admits, is that people who went through three or four treatment combos -- those with the toughest depressions to treat -- had the lowest chances of feeling better. The wellness factor How, then, do patients know if they are well enough to stop therapy? "That idea of 'well' is something patient and doctor have to agree upon," says Leuchter, a specialist in the effectiveness of depression treatments. "They have to have a meeting of the minds on the definition. One real problem is that depressed patients often have a very low bar for what they would call feeling better. They've probably been depressed for years before they come to me for treatment. During this time they've lowered the bar: This, they tell themselves, is as good as it's ever going to get." So a slight improvement in mood seems enormous, even if a depressed patient's overall emotional state is one of apathy and general listlessness and little hope for the future, a condition few non-depressed people would describe as normal. Though it may seem good to the patient, most can do better. There are scales of symptom severity, such as the Beck Depression Inventory or the Hamilton Depression Rating Scale, that Leuchter uses to rate individual symptoms, such as irritability or loss of appetite. "A 50% improvement on these scales is good," he says. "But I don't know anyone who would stop there. The acid test is getting back to full function. Are you able to work as you did before? Do you get enjoyment from life as you did before?" Adds Frank: "If you are a schoolteacher, for example, how many papers could you grade in a week before you felt depressed, and how many can you grade now? How often do you get in a fight with your wife? If it was once a month before, and it's once a month now, then you are probably back." Since "before" may be clouded in patients' minds, Frank and Leuchter like to also get opinions from spouses or other people close to patients. After the end of a depressive episode, Leuchter says, it's good to continue therapy for four to nine months. "It's like the cast on a broken leg," he says. "You need the continued support to be able to heal." Coping skills need to be honed or a stressful incident might trigger another depression. Then the patient begins to taper, whether it is drugs or psychotherapy or both, cutting the drug dose in half, or seeing a therapist every two weeks instead of every week. Then it's wait and see. "If it goes well, then cut it in half again," Frank says. With drugs, if someone tries to taper too quickly or even go cold turkey, he or she often experiences a range of physical and emotional reactions. Some people complain of sleeplessness, dizziness, muscle aches or fatigue. Mentally, many feel anxious, nervous or, not surprisingly, depressed. Often, raising the drug back to the last effective dose alleviates the symptoms. As with so many things regarding antidepressants, psychiatrists do not have hard-and-fast explanations for these effects. But it's possible that the brain might reduce its ability to produce chemicals such as serotonin while the drugs enhance the supply. When the drugs are stopped, a lack of serotonin might cause side effects until the brain regains its balance. Sometimes it doesn't go well. For patients who have three episodes of major depression during their lives, particularly if the first one hit at a young age, chances of another relapse are high, about 90%. Long-term management The woman who lost her father at age 10 fits that profile. After her initial treatment she got better and then worse. She changed drugs and doses, but the cycle continued for 18 years. She thought about killing herself; she also thought about killing others. At one point she committed herself to a hospital. The last time she tried to wean herself off medication was a year ago. "I couldn't do it," she says. She felt herself falling back into a scary, dark place. So she went back on medication. "That's frightening to me, a little. But I also know that there are meds that help. It's a lot better knowing that I don't have to go through life feeling like crap." She also credits psychotherapy with helping her identify situations that trigger depressive and anxious thoughts. It's often periods of inactivity. So she keeps herself fully booked. "I'm in L.A., I'm with dogs all day, and I'm walking them out in the sunshine, and all that feels good," she says. "I like my life. I'm able to be depressed and crack jokes. As long as I keep going in this direction, I'll be just fine." Therapy's Over. You OK With That? Janet Cromley, Los Angeles Times- 10/9/2007 You've been in psychotherapy for awhile, and you're feeling better. Much better. Is it time to quit? The answer is based, in large part, on the type of treatment. "When to end therapy depends on context and diagnosis," says Dr. Gary Kennedy, director of geriatric psychiatry at Montefiore Medical Center in New York. Certain types of treatment, such as cognitive behavior therapy, are designed to relieve disorders such as mild depression or anxiety in a short period, and the end is almost predetermined. The therapist lays out a plan with the client, sometimes with goals set by the client, and executes the plan over a few months. These therapists may even use questionnaires for measuring progress on particular concerns, such as levels of anxiety or depression. With this type of therapy, the treatment is done when symptoms have been reduced, based on the client's own assessment that he or she is feeling better and coping better. "Cognitive behavior therapy is focused and goal-oriented," says Emanuel Maidenberg, a UCLA associate clinical professor of psychiatry who uses cognitive behavior therapy to treat anxiety and depression. "From the very beginning, my client and I have developed specific goals that are measurable by definition," Maidenberg says. "We're done when both of us know that we've achieved most or all of these goals -- when you believe that you can cope with whatever life is going to present you with." The end point is less clear cut with more explorative types of approaches, such as psychodynamic therapy, in which the goal is to examine unconscious motivations and get to the "why" of the feelings and behavior. This type of therapy tends to be open-ended and the decision to end is more subjective. Nevertheless, a natural end point for the patient "is when their issues are resolved, their relationships are better, they have their lives under better control," says Dr. Marcia Kraft Goin, a professor of clinical psychiatry at USC's Keck School of Medicine and past president of the American Psychiatric Assn. Sometimes the patient will initiate the conversation about it and sometimes the therapist will, she says. In addition, there's no shame in reevaluating therapy, whatever the kind, if it clearly isn't working, writes psychotherapist Barry Reynolds, executive director of USC's Psychology Services Center, in an e-mail. "Psychologists and other therapists are obligated by their ethics codes to talk with clients about an apparent lack of progress after six months or so," he says. "The therapist should consider a change in the therapy procedures or a referral to an alternative therapist." Some therapists will wean the patient off therapy slowly. "I might suggest that we not meet the next week," Kennedy says, "and then perhaps suggest that we meet in a month, and maybe in the next two or three months, then maybe call as needed." Terminating therapy is particularly problematic for patients with certain types of mental illness -- such as repeated bouts of clinical depression -- that require extensive therapy. "If you have a chronic relapsing illness," Kennedy says, "the likelihood is that you're going to need some form of ongoing psychotherapy -- that could be in the form of counseling or a supportive relationship." "If you think about it," he says, "we don't think of diabetes or hypertension or congestive heart failure as illnesses where you're going to take medication episodically. We think of these as illnesses where you need treatment for the long run." Goin believes that handling the termination properly may be key to sustaining gains made in therapy. "In psychodynamic therapy, we believe the beginning, middle and the end" are all part of the process, she says. "It's very important not to suddenly one day come in and say 'goodbye,' but to spend a little time talking about the leaving, the saying goodbye, in order to consolidate the gains." For some, saying goodbye might require scaling back their dreams of a miracle recovery. "There are hopes and expectations that people have when they come to therapy that in many cases don't happen," Goin says. "So we talk about limitations and disappointments as well as the positive things that have happened in therapy. That way it doesn't go underground and sabotage the good work the patient has done." |